Select all docs (Max 200)
Narrow Results:
Publication Year
Medical Subject
- Activities of Daily Living 1
- Adolescent 3
- Adrenal Cortex Hormones 1
- Adult 3
- Aged 4
- Aged, 80 and over 4
- Age Factors 1
- Aging 1
- Animals 2
- Antiparasitic Agents 1
- Article 3
- Blood Pressure Monitoring, Ambulatory 1
- Cardiovascular Diseases 1
- Caregivers 2
- Child 1
- Child, Preschool 1
- Cohort Studies 1
- Communicable Disease Control 1
- Coronavirus Infections 2
- CoronaVirus Infections 1
- Coronavirus Infections/prevention & control 1
- Cost-Benefit Analysis 4
- Cost of Illness 4
- cost of informal care 1
- Costs and Cost Analysis 2
- Cost Savings 1
- COVID-19 1
- COVID-19/prevention & control 1
- Databases, Factual 1
- Decision Trees 1
- Diabetes Mellitus 1
- Disease Outbreaks 1
- Dog Diseases 1
- Dogs 1
- Drug Costs 2
- economic burden 1
- Endemic Diseases 1
- Female 4
- Fibrinolytic Agents 2
- Health Care Costs 4
- Heart Failure 1
- hemorrhage 1
- Hospital Costs 1
- Hospitalization 3
- Housing 1
- Humans 15
- Hypertension 1
- Immunization Programs 1
- Incidence 1
- indirect cost 1
- Infant 1
- Infusions, Intravenous 2
- Inpatients 1
- Ischemic Stroke 2
- Ivermectin 1
- Length of Stay 1
- Linear Models 1
- Longitudinal Studies 1
- Malaria 1
- Male 4
- Mandatory Programs 1
- Masks 2
- Mass Screening 1
- Middle Aged 4
- Middle East Respiratory Syndrome Coronavirus 2
- Models, Econometric 1
- Pandemics/prevention & control 1
- Patient Care 1
- Patient Discharge 1
- Patient Education as Topic 1
- Pneumonia, Viral/prevention & control 1
- Prevalence 1
- Program Evaluation 1
- Public Health 2
- Quality-Adjusted Life Years 2
- Quality of Life 2
- Rabies 1
- Rabies virus 1
- Refugees 2
- Regression Analysis 1
- Republic of Korea 1
- Research 1
- Restaurants 1
- Retrospective Studies 2
- Severe Acute Respiratory Syndrome 1
- Social Support 1
- Stroke 3
- Strongyloides stercoralis 1
- Strongyloidiasis 1
- Thrombolytic Therapy 2
- Time-to-Treatment 1
- Time Factors 2
- Tissue Plasminogen Activator 2
- Travel 3
- Treatment Outcome 3
- United States 6
- Vaccination 2
- Vaccines 2
- Young Adult 3
- Zoonoses 1
Personal Author
Corporate Author
Place as Subject
- California 1
- Colorado 1
- Connecticut 1
- Maryland 1
- Michigan 1
- Minnesota 1
- New Mexico 1
- New York 1
- Ohio 1
- Oregon 1
- Republic of Korea 1
- U.S. 1
- United States 1
Resource Type General
Keywords
- Accidental Falls 1
- Adolescent 1
- Adult 2
- Aged 2
- Aged, 80 and over 2
- Age Factors 3
- All Cerebrovascular disease/Stroke 1
- All rehabilitation 1
- Atrial Fibrillation 1
- atrial fibrillation 1
- Brain Ischemia 2
- Caregivers 1
- Chlorination 1
- corticosteroid 1
- Cost-benefit 1
- Cost-Benefit Analysis 1
- cost-effectiveness 1
- Cost effectiveness/economics 1
- Cost of Illness 1
- dogs 1
- economic burden of disease 1
- economic impact 1
- economics 1
- Female 3
- Fibrinolytic Agents 1
- Health Care Costs 1
- hospital admission 1
- Hospital cost 1
- Hospital Costs 1
- Hospitalization 2
- Household water treatment 1
- Humans 3
- Informal Sector 1
- inpatient 1
- International Classification of Diseases 1
- ischemic stroke 1
- Longitudinal Studies 1
- Malaria 1
- Male 3
- MERS 1
- Middle Aged 2
- Middle East respiratory syndrome 1
- Models, Economic 1
- outbreak 1
- outpatient 1
- Patient Care 1
- presumptive treat 1
- Prevalence 1
- public health 1
- Quality-Adjusted Life Years 1
- rabies incidence 1
- rabies virus 1
- Recombinant Proteins 1
- Recurrence 1
- Refugee health 1
- Refugee immunizations 1
- Registries 1
- Safe water storage 1
- Stroke 3
- stroke 1
- strongyloidiasis 1
- Survivors 1
- Tissue Plasminogen Activator 1
- tourism 1
- tPA 1
- travel industry 1
- treatment cost 1
- Treatment Outcome 1
- treatment strategies 1
- United States 4
- Vaccine costs 1
- Vaccine preventable diseases 1
- Young Adult 2
- zoonoses 1
Select all docs (Max 200)
1 -
19 of 19 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results
Refine Results:
- Activities of Daily Living (1)
- Adolescent (3)
- Adrenal Cortex Hormones (1)
- Adult (3)
- Aged (4)
- Aged, 80 and over (4)
- Age Factors (1)
- Aging (1)
- Animals (2)
- Antiparasitic Agents (1)
- Article (3)
- Blood Pressure Monitoring, Ambulatory (1)
- Cardiovascular Diseases (1)
- Caregivers (2)
- Child (1)
- Child, Preschool (1)
- Cohort Studies (1)
- Communicable Disease Control (1)
- Coronavirus Infections (2)
- CoronaVirus Infections (1)
- Coronavirus Infections/prevention & control (1)
- Cost-Benefit Analysis (4)
- Cost of Illness (4)
- cost of informal care (1)
- Costs and Cost Analysis (2)
- Cost Savings (1)
- COVID-19 (1)
- COVID-19/prevention & control (1)
- Databases, Factual (1)
- Decision Trees (1)
- Diabetes Mellitus (1)
- Disease Outbreaks (1)
- Dog Diseases (1)
- Dogs (1)
- Drug Costs (2)
- economic burden (1)
- Endemic Diseases (1)
- Female (4)
- Fibrinolytic Agents (2)
- Health Care Costs (4)
- Heart Failure (1)
- hemorrhage (1)
- Hospital Costs (1)
- Hospitalization (3)
- Housing (1)
- Humans (15)
- Hypertension (1)
- Immunization Programs (1)
- Incidence (1)
- indirect cost (1)
- Infant (1)
- Infusions, Intravenous (2)
- Inpatients (1)
- Ischemic Stroke (2)
- Ivermectin (1)
- Length of Stay (1)
- Linear Models (1)
- Longitudinal Studies (1)
- Malaria (1)
- Male (4)
- Mandatory Programs (1)
- Masks (2)
- Mass Screening (1)
- Middle Aged (4)
- Middle East Respiratory Syndrome Coronavirus (2)
- Models, Econometric (1)
- Pandemics/prevention & control (1)
- Patient Care (1)
- Patient Discharge (1)
- Patient Education as Topic (1)
- Pneumonia, Viral/prevention & control (1)
- Prevalence (1)
- Program Evaluation (1)
- Public Health (2)
- Quality-Adjusted Life Years (2)
- Quality of Life (2)
- Rabies (1)
- Rabies virus (1)
- Refugees (2)
- Regression Analysis (1)
- Republic of Korea (1)
- Research (1)
- Restaurants (1)
- Retrospective Studies (2)
- Severe Acute Respiratory Syndrome (1)
- Social Support (1)
- Stroke (3)
- Strongyloides stercoralis (1)
- Strongyloidiasis (1)
- Thrombolytic Therapy (2)
- Time-to-Treatment (1)
- Time Factors (2)
- Tissue Plasminogen Activator (2)
- Travel (3)
- Treatment Outcome (3)
- United States (6)
- Vaccination (2)
- Vaccines (2)
- Young Adult (3)
- Zoonoses (1)
- Accidental Falls (1)
- Adolescent (1)
- Adult (2)
- Aged (2)
- Aged, 80 and over (2)
- Age Factors (3)
- All Cerebrovascular disease/Stroke (1)
- All rehabilitation (1)
- Atrial Fibrillation (1)
- atrial fibrillation (1)
- Brain Ischemia (2)
- Caregivers (1)
- Chlorination (1)
- corticosteroid (1)
- Cost-benefit (1)
- Cost-Benefit Analysis (1)
- cost-effectiveness (1)
- Cost effectiveness/economics (1)
- Cost of Illness (1)
- dogs (1)
- economic burden of disease (1)
- economic impact (1)
- economics (1)
- Female (3)
- Fibrinolytic Agents (1)
- Health Care Costs (1)
- hospital admission (1)
- Hospital cost (1)
- Hospital Costs (1)
- Hospitalization (2)
- Household water treatment (1)
- Humans (3)
- Informal Sector (1)
- inpatient (1)
- International Classification of Diseases (1)
- ischemic stroke (1)
- Longitudinal Studies (1)
- Malaria (1)
- Male (3)
- MERS (1)
- Middle Aged (2)
- Middle East respiratory syndrome (1)
- Models, Economic (1)
- outbreak (1)
- outpatient (1)
- Patient Care (1)
- presumptive treat (1)
- Prevalence (1)
- public health (1)
- Quality-Adjusted Life Years (1)
- rabies incidence (1)
- rabies virus (1)
- Recombinant Proteins (1)
- Recurrence (1)
- Refugee health (1)
- Refugee immunizations (1)
- Registries (1)
- Safe water storage (1)
- Stroke (3)
- stroke (1)
- strongyloidiasis (1)
- Survivors (1)
- Tissue Plasminogen Activator (1)
- tourism (1)
- tPA (1)
- travel industry (1)
- treatment cost (1)
- Treatment Outcome (1)
- treatment strategies (1)
- United States (4)
- Vaccine costs (1)
- Vaccine preventable diseases (1)
- Young Adult (2)
- zoonoses (1)
- :Wang, Guijing ;Joo, Heesoo5 2015 | Stroke. 46(5):1314-1320:Background and purposeHospital costs associated with atrial fibrillation (AFib) among stroke patients have not been well-studied, especially among peo...
- :Pezzi, Clelia ;McCulloch, Audrey5 11 2018 | Vaccine. 36(20):2902-2909:Background:Newly arrived refugees are offered vaccinations during domestic medical examinations. Vaccination practices and costs for refugees have not...
- :Joo, Heesoo ;Wang, Guijing2 16 2016 | Stroke Vasc Neurol. 1(1):8-15:IntroductionIntravenous tissue plasminogen activator (IV tPA) is a globally recommended treatment for acute ischemic stroke patients. We examined IV t...
- :Joo, Heesoo ;Fang, JingOct 25 2014 | Am Heart J. 169(1):142-48.e2.:BackgroundHeart failure is a serious health condition that requires a significant amount of informal care. However, informal caregiving costs associat...
- :Joo, Heesoo ;Wang, Guijing12 2017 | Am J Prev Med. 53(6 Suppl 2):S205-S212:IntroductionStudies have demonstrated that intravenous recombinant tissue plasminogen activator (IV rtPA) is a cost-effective treatment for acute isch...
- :Joo, Heesoo ;Wang, Guijing12-2017 | Am J Prev Med. 53(6 Suppl 2):S197-S204:IntroductionOlder adults are at high risk for stroke and falls, both of which require a large amount of informal caregiving. However, the economic bur...
- :Joo, Heesoo ;George, Mary G.Jun 21 2014 | J Stroke Cerebrovasc Dis. 23(7):1753-1763.:Stroke is a leading cause of mortality and long-term disability. However, the indirect costs of stroke, such as productivity loss and costs of informa...
- :Joo, Heesoo ;Dunet, Diane O.11 11 2014 | Neurology. 83(20):1831-1837:ObjectivesWe estimated the informal caregiving hours and costs associated with stroke.MethodsWe selected persons aged 65 and older in 2006 and who wer...
- :Joo, Heesoo ;Maskery, BrianSeptember 14 2017 | Vaccine. 36(20):2896-2901:BackgroundVaccination Program for US-bound Refugees (VPR) currently provides one or two doses of some age-specific Advisory Committee on Immunization ...
- :Joo, Heesoo ;Wang, Guijing4 28 2017 | Stroke Vasc Neurol. 2(2):73-83:BackgroundIntravenous recombinant tissue plasminogen activator (IV rtPA) is recommended treatment for acute ischemic stroke patients, but the cost-eff...
- :Zhang, Donglan ;Wang, Guijing12 2017 | Am J Prev Med. 53(6 Suppl 2):S121-S130:ContextEffective community-based interventions are available to control hypertension. It is important to determine the economics of these intervention...
- :Joo, Heesoo ;Zhang, PingDec 19 2016 | Qual Life Res. 26(6):1379-1386.:PurposePatients with cardiovascular disease (CVD) or diabetes often require informal care. The burden of informal care, however, was not fully integra...
- :Joo, Heesoo ;Maskery, Brian A.8 03 2024 | J Travel Med. 31(6):Background:The risk of developing strongyloidiasis hyperinfection syndrome appears to be elevated among individuals who initiate corticosteroid treatm...Public Access Available on:August 03, 2025
- :Joo, Heesoo ;Henry, Ronald E.2019 | Travel Med Infect Dis. 30:54-66:Background:The experience of previous sizable outbreaks may affect travelers’ decisions to travel to an area with an ongoing outbreak.Methods:We est...
- :Joo, Heesoo ;Maskery, Brian A.2019 | Health Secur. 17(2):100-108:BackgroundThe 2015 Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea (ROK) is an example of an infectious disease outbreak ini...
- :Joo, Heesoo ;Miller, Gabrielle F.February 12 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):SARS-CoV-2, the Virus that causes coronaVirus disease 2019 (COVID-19), is transmitted predominantly by respiratory droplets generated when infected pe...
- :Joo, Heesoo ;Miller, Gabrielle F.February 5, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR):What is already known about this topic? Wearing masks is recommended to mitigate the spread of COVID-19.What is added by this report? During March 22â...
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.